3i invests in ten23 health
3i Group has partnered with Professor Dr Hanns-Christian Mahler to create ten23 health, a pure-play, patient-centric and sustainable biologics drug product contract development and manufacturing organisation (CDMO) focused on helping innovative biotech and pharma customers develop and commercialise injectable biopharmaceutical drugs. Mahler, CEO of ten23 health, previously built a highly
